title: Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
authors.forename: Wan Kyu
authors.initials: WK
authors.lastname: Eo
authors.forename: Se Hyun
authors.initials: SH
authors.lastname: Kim
authors.forename: Seong Ha
authors.initials: SH
authors.lastname: Cheon
authors.forename: Sang Hun
authors.initials: SH
authors.lastname: Lee
authors.forename: Jong Soo
authors.initials: JS
authors.lastname: Jeong
authors.forename: Yang Soo
authors.initials: YS
authors.lastname: Kim
authors.forename: Hee Kyung
authors.initials: HK
authors.lastname: Chang
authors.forename: Kee Suck
authors.initials: KS
authors.lastname: Suh
authors.forename: Heung Yeol
authors.initials: HY
authors.lastname: Kim
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001706:Biopsy; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000276:immunology / Q000627:therapeutic use; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D013262:Stevens-Johnson Syndrome / Q000188:drug therapy / Q000276:immunology / Q000473:pathology*; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous; D013792:Thalidomide; D003907:Dexamethasone